7191-39-1Relevant academic research and scientific papers
New cyclic skin whiteninig agent
-
Paragraph 0116; 0173-0174, (2016/11/21)
In the present invention, provided is a skin whitening agent, which is easily synthesized without side effects for skin and has an outstanding effect of inhibiting pigmentation on skin due to an outstanding effect of inhibiting the creation of melanine where a cyclic derivative compound or pharmaceutically acceptable salt thereof has a chemical structure in formula (I) and is accordingly used to achieve the purpose of the present invention. In the present invention, provided is a cyclic derivative compound or pharmaceutically acceptable salt thereof, which has an effect of whitening skin and a chemical structure in formula (I) where A is derived from an aromatic cyclic compound; B is derived from among hydrogen, O which is oxo, NH_2 which is amino, NH which is imino, C1-C10 of saturated or unsaturated straight or branched chain alkyl group, alkoxy, mono alkyl amino group or dialkyl amino group; and C_n, C_n+1 and C_n+2 are three neighboring carbons in the cyclic compound wherein n is a positive integer.COPYRIGHT KIPO 2015
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
Tourteau, Aurélien,Andrzejak, Virginie,Body-Malapel, Mathilde,Lemaire, Lucas,Lemoine, Amélie,Mansouri, Roxane,Djouina, Madjid,Renault, Nicolas,El Bakali, Jamal,Desreumaux, Pierre,Muccioli, Giulio G.,Lambert, Didier M.,Chavatte, Philippe,Rigo, Beno?t,Leleu-Chavain, Natascha,Millet, Régis
, p. 5383 - 5394 (2013/09/02)
Recent investigations showed that anandamide, the main endogenous ligand of CB1 and CB2 cannabinoid receptors, possesses analgesic, antidepressant and anti-inflammatory effects. In the perspective to treat inflammatory bowel disease (IBD), our approach was to develop new selective CB2 receptor agonists without psychotropic side effects associated to CB1 receptors. In this purpose, a new series of 3-carboxamido-5- aryl-isoxazoles, never described previously as CB2 receptor agonists, was designed, synthesized and evaluated for their biological activity. The pharmacological results have identified great selective CB2 agonists with in vivo anti-inflammatory activity in a DSS-induced acute colitis mouse model.
Selectivity engineering of phase transfer catalyzed alkylation of 2′-hydroxyacetophenone: Enhancement in rates and selectivity by creation of a third liquid phase
Yadav, Ganapati D.,Desai, Neesha M.
, p. 749 - 756 (2012/12/26)
Enhancements in rate of reaction and selectivity of the desired product in biphasic reactions are achieved by creating a third liquid phase, under appropriate conditions, where the third liquid phase is the locale of the main reaction, having a dramatic effect on product distribution in complex chemical reactions. Thus, in the case of phase transfer catalysis (PTC), conversion of liquid-liquid (L-L) PTC into liquid-liquid-liquid (L-L-L) PTC is of considerable techno-commercial interest resulting in waste minimization which is a major theme of green chemistry. Etherification of 2′-hydroxyacetophenone with 1-bromopentane, under traditional liquid-liquid phase transfer catalysis, results in loss of catalyst. However, the transformation of two liquid phases into three liquid phases (L-L-L) PTC leads enhancement in rates by orders of magnitude, with 100% conversion of the limiting reactant 1-bromopentane and 100% selectivity to 2′-pentyloxyacetophenone. This strategy eliminates separation problems and results in high reaction rates reducing the total reaction time. Moreover, the catalyst-rich third phase is recycled more than 7 times without loss in activity. The kinetics of the reaction are studied in great detail. There is a substantial reduction in activation energy under L-L-L PTC vis-a-vis L-L PTC, where the locale of the reaction is shifted from the organic phase to the third phase.
Discovery of α,γ-Diketo Acids as Potent Selective and Reversible Inhibitors of Hepatitis C Virus NS5b RNA-Dependent RNA Polymerase
Summa, Vincenzo,Petrocchi, Alessia,Pace, Paola,Matassa, Victor G.,De Francesco, Raffaele,Altamura, Sergio,Tomei, Licia,Koch, Uwe,Neuner, Philippe
, p. 14 - 17 (2007/10/03)
α,γ-Diketo acids (DKA) were discovered from screening as selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase. The diketo acid moiety proved essential for activity, while substitution on the γ position was necessary for selectivity and potency. Optimization led to the identification of a DKA inhibitor of NS5b polymerase with IC50 = 45 nM, one of the most potent HCV NS5b polymerase inhibitors reported.
